PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'UNC Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.\', \'Family Health International, Durham, NC, USA.\', \'FLACSO-Argentina and CONICET, Buenos Aires, Argentina.\', \'Columbia University, New York, NY, USA.\', \'Botswana Harvard AIDS Institute Partnership Princess Marina Hospital, Gaborone, Botswana.\', \'Center for Healthy Communities, University of California Riverside School of Medicine, Riverside, CA, USA.\', \'NIAID HIV Vaccine Trials Network, Seattle, WA, USA.\', \'Berman Institute of Bioethics, Johns Hopkins University, 1809 Ashland Ave, Baltimore, MD, 21205, USA. jsugarman@jhu.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12910-021-00575-w
?:doi
?:hasPublicationType
?:journal
  • BMC medical ethics
is ?:pmid of
?:pmid
?:pmid
  • 33494754
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.016
?:rankingScore_hIndex
  • 33
?:title
  • HIV prevention research and COVID-19: putting ethics guidance to the test.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33494754>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33494754>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all